Stem-Cells: To Patent or Not?

In spare moments, I’ve been wondering about the Advocate-General of European Court of Justice’s recent recommendation that patents involving human embryonic stem-cells be prohibited, and the response that it’s generated.  One of the best-publicised responses was the letter from Austin Smith et al that appeared in Nature, which complained that the recommendation would be bad […]

Read More…

INCB: Wrong on Drugs Policy

It’s a while since I’ve said anything about drug policy, but a story in the BMJ a couple of weeks ago caught my eye.  It would appear that the International Narcotics Control Board, a UN agency, has issued a report in which it advocates the prohibition of whole classes of substance: National governments need to […]

Read More…

MSF writes to the EU

One of the things we’re interested in here in Manchester is the problem of how to reconcile the need to incentivise and reward research in the medical sector with the palpable need in the developing world for affordable medicines.  This quandry is at the heart of the Manchester Manifesto. A lot of emphasis has been […]

Read More…